ArticleJournal of Korean medical science2026
The SHIPE Index: A Tertile-Based Approach to Predict End-Stage Kidney Disease in ANCA-Associated Vasculitis.
Article in Journal of Korean medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThis study aimed to develop a simple, robust, and ethnoregion-specific index for predicting progression to end-stage kidney disease (ESKD) in Korean patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
methodsBaseline data from 239 Korean patients with AAV enrolled in a tertiary hospital cohort were analyzed to identify independent predictors of ESKD using univariable and multivariable Cox proportional hazards models. The SHIPE (Summation of the Highest tertiles of Independent Predictors of ESKD) index was constructed by summing the highest tertiles of the identified predictors: Five-Factor Score (≥ 2) and serum creatinine (≥ 1.3 mg/dL), with 1 point assigned to each criterion met. Cumulative ESKD-free survival rates across SHIPE index scores were compared using Kaplan-Meier analysis.
resultsA SHIPE index score of 2 was significantly associated with lower cumulative ESKD-free survival rate compared to scores of 0 or 1 (
conclusionThe SHIPE index is a novel, robust, and convenient tool for predicting ESKD progression in Korean patients with AAV. This study introduces a practical framework for developing tailored prediction indices that can be adapted for diverse ethnic and regional populations. Its simplicity and practical applicability make it well-suited for routine clinical use. Future prospective studies are needed to validate the SHIPE index in larger, multi-ethnic cohorts and ensure its broader applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.